INSIGHTS ON DRUG DEVELOPMENT

• Extraction And Chemical Characterization Pitfalls In Complex Medical Devices

  Standard extraction protocols routinely fail tissue-derived products, hydrogels, absorbables, and silicone implants. Learn the material-specific study design strategies that prevent regulatory rejection and repeat work.

• Enable Low Volume Delivery Of Proteins In Aqueous Solutions

  Achieve ultra-low volume dispensing of proteins and aqueous solutions without surfactants with consistent precision, minimal contamination, and broad compatibility to streamline your lab workflow.

• How Adept Formulation Helps Overcome Manufacturability Challenges

  Initial development, scaleup, and tech transfer of complex multi-particulate drug systems requires meticulous planning to mitigate manufacturing risks.

• Scientific Data Is Not AI‑Ready By Default

  Convert siloed laboratory data into trusted, AI-ready assets. Learn to enforce data integrity principles at the point of origin to streamline analytics and reduce GxP compliance risks.

• Early Automation Integration Reshapes How Drugs Move

  10/19/2026

  Introducing automation during R&D rather than in Phase 3 changes how processes scale. Unified data and standards-based control logic carry across bench, pilot, and commercial stages with less rework.

• The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly

  3/3/2025

  In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.

• Improve Bioanalysis Workflows With Integrated Technologies

  8/18/2026

  Improve bioanalysis workflows with integrated technologies designed for sensitive biomolecules. Explore how biocompatible systems can support sample integrity, reliable performance, and evolving needs.

• AI Based Screening And Selection Of Co-Formers For Co-Crystallization

  11/4/2025

  Explore how AI and quantum chemistry are accelerating co-crystal screening and solving solubility challenges in drug development, as well as key technical considerations for identifying optimal co-formers.

• Integrating High-Content Imaging With Traditional Plate-Based Screening

  5/6/2026

  Gain mechanistic insights beyond traditional viability assays, revealing nuanced cellular phenotypes and strengthening early drug discovery decisions without sacrificing throughput or efficiency.